Peer-influenced content. Sources you trust. No registration required. This is HCN.
Psych Congress Network
Although not remarkably high, a 2.8% development of psychotic symptoms represents a nonnegligible figure and lends further meta-analytic support to the 2007 FDA change in the drug label for stimulants.
Psychiatry October 9th 2025
BlackDoctor.org (BDO)
“Following a prescribed treatment plan can help people manage their symptoms and improve their quality of life.”
Family Medicine/General Practice July 31st 2025
Healthline
Studies show that bipolar disorder patients with severe symptoms demonstrate significant impairment in prospective memory – the ability to remember and execute planned future actions.
Psychiatry December 4th 2024
Lithium continues to be recognized as the most reliable mood stabilizer for bipolar disorder patients with a history of mania, necessitating precise management of dosages to prevent significant side effects.
Psychiatry May 7th 2024
Epoch Health
This recent Supreme Court ruling sheds light on the critical intersection of mental health and legal standards, offering an essential perspective for healthcare professionals involved in forensic or psychiatric fields.
Psychiatry April 9th 2024
Psychiatrist.com
Recent advancements in the treatment of acute agitation offer promising non-invasive options, such as inhaled loxapine and sublingual dexmedetomidine, aligning with the shift towards patient-centered care and minimizing the use of coercive measures.
Psychiatry February 13th 2024